JP2002515904A - セルトインドールの製造方法 - Google Patents
セルトインドールの製造方法Info
- Publication number
- JP2002515904A JP2002515904A JP54871198A JP54871198A JP2002515904A JP 2002515904 A JP2002515904 A JP 2002515904A JP 54871198 A JP54871198 A JP 54871198A JP 54871198 A JP54871198 A JP 54871198A JP 2002515904 A JP2002515904 A JP 2002515904A
- Authority
- JP
- Japan
- Prior art keywords
- fluorophenyl
- indole
- chloro
- acid
- alkali metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 60
- 238000000034 method Methods 0.000 claims abstract description 48
- -1 alkali metal salt Chemical class 0.000 claims abstract description 42
- VRJHQPZVIGNGMX-UHFFFAOYSA-N 4-piperidinone Chemical compound O=C1CCNCC1 VRJHQPZVIGNGMX-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 26
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 26
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims abstract description 25
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 24
- JYEKQDWSLSXYTJ-UHFFFAOYSA-N 5-chloro-1-(4-fluorophenyl)indole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C=C1 JYEKQDWSLSXYTJ-UHFFFAOYSA-N 0.000 claims abstract description 22
- QVTQYSFCFOGITD-UHFFFAOYSA-N 2,5-dichlorobenzoic acid Chemical compound OC(=O)C1=CC(Cl)=CC=C1Cl QVTQYSFCFOGITD-UHFFFAOYSA-N 0.000 claims abstract description 18
- ZFIMCCCQJDZLCT-UHFFFAOYSA-N 2-(4-fluoroanilino)acetic acid Chemical compound OC(=O)CNC1=CC=C(F)C=C1 ZFIMCCCQJDZLCT-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000004471 Glycine Substances 0.000 claims abstract description 13
- WLQZFXJVVNNEJU-UHFFFAOYSA-N 5-chloro-1-(4-fluorophenyl)-3-(1,2,3,6-tetrahydropyridin-4-yl)indole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C(C=2CCNCC=2)=C1 WLQZFXJVVNNEJU-UHFFFAOYSA-N 0.000 claims abstract description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003054 catalyst Substances 0.000 claims abstract description 8
- JBOPQACSHPPKEP-UHFFFAOYSA-N Indoxyl acetate Chemical compound C1=CC=C2C(OC(=O)C)=CNC2=C1 JBOPQACSHPPKEP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000010949 copper Substances 0.000 claims abstract description 7
- YGSFFDHIYYOVHV-UHFFFAOYSA-N 1-(2-chloroethyl)imidazolidin-2-one Chemical compound ClCCN1CCNC1=O YGSFFDHIYYOVHV-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000002904 solvent Substances 0.000 claims abstract description 6
- 229910052802 copper Inorganic materials 0.000 claims abstract description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 238000010992 reflux Methods 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 13
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 9
- 239000011707 mineral Substances 0.000 claims description 9
- 239000002585 base Substances 0.000 claims description 7
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims description 4
- 150000008041 alkali metal carbonates Chemical class 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- JQKIHHHTOFFTAM-UHFFFAOYSA-N piperidin-4-one;hydrate Chemical compound O.O=C1CCNCC1 JQKIHHHTOFFTAM-UHFFFAOYSA-N 0.000 claims description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 239000012429 reaction media Substances 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- 229910001413 alkali metal ion Inorganic materials 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 230000008030 elimination Effects 0.000 claims description 2
- 238000003379 elimination reaction Methods 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- YCXCLZSLZGBCTA-UHFFFAOYSA-N 5-chloro-1-(4-fluorophenyl)-3-piperidin-4-ylindole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C(C2CCNCC2)=C1 YCXCLZSLZGBCTA-UHFFFAOYSA-N 0.000 claims 1
- 125000001207 fluorophenyl group Chemical group 0.000 claims 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 abstract 1
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- 239000012065 filter cake Substances 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 7
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 7
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 7
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 229940095064 tartrate Drugs 0.000 description 6
- 239000012043 crude product Substances 0.000 description 5
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 4
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 230000000561 anti-psychotic effect Effects 0.000 description 3
- 239000011260 aqueous acid Substances 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 159000000001 potassium salts Chemical class 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229910000906 Bronze Inorganic materials 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000010974 bronze Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- APQPPWOSXDULBB-UHFFFAOYSA-N piperidin-2-one;hydrate Chemical compound O.O=C1CCCCN1 APQPPWOSXDULBB-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- VJBAGQQJVTVKKP-UHFFFAOYSA-N 1h-indole;methanol Chemical compound OC.C1=CC=C2NC=CC2=C1 VJBAGQQJVTVKKP-UHFFFAOYSA-N 0.000 description 1
- XNTHDQDMSUWQKT-UHFFFAOYSA-N 3-(2-chloroethyl)-1h-imidazol-2-one Chemical compound ClCCN1C=CNC1=O XNTHDQDMSUWQKT-UHFFFAOYSA-N 0.000 description 1
- SLNKACMTMZYMNA-UHFFFAOYSA-N 3-(furan-2-yl)aniline Chemical compound NC1=CC=CC(C=2OC=CC=2)=C1 SLNKACMTMZYMNA-UHFFFAOYSA-N 0.000 description 1
- HAJLBMYQEZHEBM-UHFFFAOYSA-N 3-fluorofuran Chemical compound FC=1C=COC=1 HAJLBMYQEZHEBM-UHFFFAOYSA-N 0.000 description 1
- AWTSMTYMNVZGGN-UHFFFAOYSA-N 5-chloro-1-(4-fluorophenyl)indole;[5-chloro-1-(4-fluorophenyl)indol-3-yl] acetate Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C=C1.C12=CC=C(Cl)C=C2C(OC(=O)C)=CN1C1=CC=C(F)C=C1 AWTSMTYMNVZGGN-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000001358 L(+)-tartaric acid Substances 0.000 description 1
- 235000011002 L(+)-tartaric acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-LWMBPPNESA-N L-(+)-Tartaric acid Natural products OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 1
- 241001572354 Lycaena hyllus Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241001274216 Naso Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- ORYHRBOKCCLJRE-UHFFFAOYSA-N [5-chloro-1-(4-fluorophenyl)indol-3-yl] acetate Chemical compound C12=CC=C(Cl)C=C2C(OC(=O)C)=CN1C1=CC=C(F)C=C1 ORYHRBOKCCLJRE-UHFFFAOYSA-N 0.000 description 1
- PAAZCQANMCYGAW-UHFFFAOYSA-N acetic acid;2,2,2-trifluoroacetic acid Chemical compound CC(O)=O.OC(=O)C(F)(F)F PAAZCQANMCYGAW-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- ZFTJHOCQKUMVNQ-UHFFFAOYSA-M potassium;2,5-dichlorobenzoate Chemical compound [K+].[O-]C(=O)C1=CC(Cl)=CC=C1Cl ZFTJHOCQKUMVNQ-UHFFFAOYSA-M 0.000 description 1
- RZMJGBZRIUQCKK-UHFFFAOYSA-M potassium;2-(4-fluoroanilino)acetate Chemical compound [K+].[O-]C(=O)CNC1=CC=C(F)C=C1 RZMJGBZRIUQCKK-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003215 serotonin 5-HT2 receptor antagonist Substances 0.000 description 1
- GZKLJWGUPQBVJQ-UHFFFAOYSA-N sertindole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C(C2CCN(CCN3C(NCC3)=O)CC2)=C1 GZKLJWGUPQBVJQ-UHFFFAOYSA-N 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 231100000736 substance abuse Toxicity 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 125000005942 tetrahydropyridyl group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
- C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
- C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.2,5-ジクロロ安息香酸をN-(4-フルオロフエニル)グリシンで銅触媒の存在下 にアリール化することから成るN-(4-フルオロフエニル)-N-(2-カルボキシ-4- クロロフエニル)-グリシンの製造方法に於て、反応式 (式中、M及びM2はアルカリ金属イオンである。) に従って2,5-ジクロロ安息香酸のアルカリ金属塩とN-(4-フルオロフエニル)グ リシンのアルカリ金属塩を水性アルカリ性環境下で銅触媒の存在下に反応させ ることを特徴とする上記方法。 2.反応を高められた温度で、好ましくは80℃〜媒体の還流温度で、特にほぼ還 流温度で実施する、請求の範囲1記載の方法。 3.反応媒体が水又は補助溶剤が添加された水である、請求の範囲1又は2記載 の方法。 4.水を溶剤として使用する、請求の範囲3記載の方法。 5.水の量が2,5-ジクロロ安息香酸1g当たり10mlより少ない、好ましくは5ml より少ない、請求の範囲3又は4記載の方法。 6.水の量が2,5-ジクロロ安息香酸1g当たり3.5mlより少ない、好ましくは2.5 mlより少ない、請求の範囲5記載の方法。 7.使用されるアルカリ金属塩がリチウム-、ナトリウム-又はカリウム塩である 、請求の範囲1ないし6のいずれかに記載の方法。 8.反応成分の同一塩、好ましくはカリウム塩を使用する、請求の範囲7記載の 方法。 9.塩基がアルカリ金属炭酸塩、好ましくはLi2CO3,Na2CO3又はK2CO3である、 請求の範囲1ないし8のいずれかに記載の方法。 10.アルカリ金属炭酸塩のアルカリ金属が反応成分のアルカリ金属と同一である 、請求の範囲9記載の方法。 11.塩基が炭酸カリウムである、請求の範囲1ないし8のいずれかに記載の方法 。 12.塩基の量が、2,5-ジクロロ安息香酸の化学量論量よりも多い、請求の範囲1 ないし11のいずれかに記載の方法。 13.触媒が銅-ブロンズである、請求の範囲1ないし12のいずれかに記載の方 法。 14.N-(4-フルオロフエニル)グリシンのアルカリ金属塩の量と2,5-ジクロロ安息 香酸のアルカリ金属塩の量の割合が、0.5〜3.0、好ましくは1.0〜2.5、特に2. 0〜2.3モル/モルである、請求の範囲1ないし13のいずれかに記載の方法。 15.5-クロロ-1-(4-フルオロフエニル)インドールと4-ピペリドンを鉱酸と酢酸 の混合物中で反応させることを特徴とする、5-クロロ-1-(4-フルオロフエニル )-3-(1,2,3,6-テトラヒドロピリジン-4-イル)インドールの製造方法。 16.4-ピペリドンを4-ピペリドン-水和物、塩酸塩の形で使用する、請求の範囲 15記載の方法。 17.使用される鉱酸がリン酸、硝酸、硫酸又は塩酸である、請求の範囲15又は 16記載の方法。 18.使用される鉱酸が濃塩酸である、請求の範囲17記載の方法。 19.5-クロロ-1-(4-フルオロフエニル)インドール1当量あたり4-ピペリドン少 なくとも1.5当量を使用する、請求の範囲15又は16記載の方法。 20.5-クロロ-1-(4-フルオロフエニル)インドール1当量あたり4-ピペリドン少 なくとも1.75当量を使用する、請求の範囲19記載の方法。 21.5-クロロ-1-(4-フルオロフエニル)インドール1当量あたり4-ピペリドン少 なくとも2.0当量を使用する、請求の範囲20記載の方法。 22.塩酸を5-クロロ-1-(4-フルオロフエニル)インドール1gあたり濃塩酸少なく とも2.5lの量で使用する、請求の範囲18記載の方法。 23.5-クロロ-1-(4-フルオロフエニル)インドール1gあたり酢酸少なくとも8ml を使用する、請求の範囲15又は16記載の方法。 24.5-クロロ-1-(4-フルオロフエニル)インドール1gあたり酢酸少なくとも10ml を使用する、請求の範囲23記載の方法。 25.5-クロロ-1-(4-フルオロフエニル)インドール1gあたり酢酸10-14mlを使用 する、請求の範囲24記載の方法。 26.前記割合が5-クロロ-1-(4-フルオロフエニル)インドール1gあたり濃塩酸3. 5〜5mlである、請求の範囲22記載の方法。 27.酢酸と濃塩酸の比率が2:1〜4:1(容量/容量)である、請求の範囲18 記載の方法。 28.請求の範囲1ないし14のいずれかに記載の方法に従ってN-(4-フルオロフ エニル)-N-(2-カルボキシ-4-クロロフエニル)グリシンを製造し及び(又は) 請求の範囲15ないし27のいずれかに記載の方法に従って5-クロロ-1-(4-フ ルオロフエニル)-3-(1,2,3,6-テトラヒドロピリジン-4-イル)インドールを製 造することを特徴とする、セルトインドールの製造方法。 29.a)2,5-ジクロロ安息香酸のアルカリ金属塩とN-(4-フルオロフエニル)グリ シンのアルカリ金属塩を水性アルカリ性環境下に銅触媒の存在下に反応させ て、N-(4-フルオロフエニル)-N-(2-カルボキシ-4-クロロフエニル)グリシン を請求の範囲1ないし14のいずれかに記載の方法に従って製造し、 b)N-(4-フルオロフエニル)-N-(2-カルボキシ-4-クロロフエニル)グリシンを 、無水酢酸/酢酸アルカリ金属塩、好ましくは酢酸ナトリウムを用いて閉環 して、対応する3-アセトキシ-インドールとし、 c)3-アセトキシ-インドールを還元し、次いで d)H2Oを離脱し、それによって5-クロロ-1-(4-フルオロフエニル)インドール が得られ、 e)酢酸と濃HClの混合物中で請求の範囲15ないし27のいずれかに記載の方法 に従って5-クロロ-1-(4-フルオロフエニル)インドールと4-ピペリドンを反 応させ、 f)5-クロロ-1-(4-フルオロフエニル)-3-(ピペリジン-4-イル)インドールを 得るために、生じた5-クロロ-1-(4-フルオロフエニル)-3-(1,2,3,6-テトラ ヒドロピリジン-4-イル)インドールを還元し、 g)上記f)の生成物と1-(2-クロロエチル)-2-イミダゾリジノンを反応させ るか又は h)5-クロロ-1-(4-フルオロフエニル)-3-(1,2,3,6-テトラヒドロピリジン-4- イル)インドールと1-(2-クロロエチル)-2-イミダゾリジノンを反応させ、次 いで生成物を還元し、それによってセルトインドールが得られることを 特徴とする、セルトインドールの製造方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4601197P | 1997-05-09 | 1997-05-09 | |
DK53697 | 1997-05-09 | ||
US0536/97 | 1997-05-09 | ||
US60/046,011 | 1997-05-09 | ||
PCT/DK1998/000183 WO1998051685A1 (en) | 1997-05-09 | 1998-05-07 | Method of manufacturing sertindole |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002515904A true JP2002515904A (ja) | 2002-05-28 |
Family
ID=26064179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54871198A Ceased JP2002515904A (ja) | 1997-05-09 | 1998-05-07 | セルトインドールの製造方法 |
Country Status (28)
Country | Link |
---|---|
US (1) | US6335463B1 (ja) |
EP (2) | EP1260511B1 (ja) |
JP (1) | JP2002515904A (ja) |
KR (2) | KR100546477B1 (ja) |
CN (2) | CN1243001C (ja) |
AT (2) | ATE286047T1 (ja) |
AU (1) | AU731835B2 (ja) |
BG (1) | BG64007B1 (ja) |
BR (1) | BR9808740A (ja) |
CA (1) | CA2288334C (ja) |
CZ (2) | CZ298509B6 (ja) |
DE (2) | DE69821477T2 (ja) |
DK (2) | DK0983264T3 (ja) |
EA (1) | EA003248B1 (ja) |
ES (2) | ES2213897T3 (ja) |
HK (1) | HK1029583A1 (ja) |
HU (1) | HU226858B1 (ja) |
IL (1) | IL132461A (ja) |
IS (2) | IS2158B (ja) |
NO (2) | NO325918B1 (ja) |
NZ (1) | NZ500700A (ja) |
PL (1) | PL191174B1 (ja) |
PT (2) | PT1260511E (ja) |
SI (2) | SI1260511T1 (ja) |
SK (2) | SK285410B6 (ja) |
TR (2) | TR199902759T2 (ja) |
UA (1) | UA61105C2 (ja) |
WO (1) | WO1998051685A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007522206A (ja) * | 2004-02-12 | 2007-08-09 | エスケー ケミカルズ カンパニー リミテッド | 置換ベンゾピラン化合物の製造方法 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489341B1 (en) | 1999-06-02 | 2002-12-03 | Sepracor Inc. | Methods for the treatment of neuroleptic and related disorders using sertindole derivatives |
AR039116A1 (es) * | 2002-03-27 | 2005-02-09 | Lundbeck & Co As H | Metodo para la manufactura de sertindol |
EP1575882A4 (en) * | 2002-08-02 | 2008-04-02 | Rhodia Pharma Solution Inc | COPPER CATALYZED ARYLATION |
US7608630B2 (en) | 2004-01-30 | 2009-10-27 | Hainan Yangpu New Special Pharmaceutical Co., Ltd. | Marasmius androsaceus L.es Fr extract, piperidone derivative, and their use for the preparation of hypertensives |
US20070212412A1 (en) * | 2005-09-08 | 2007-09-13 | H. Lundbeck A/S | Stable solid formulation of sertindole |
TW200821296A (en) * | 2006-06-01 | 2008-05-16 | Lundbeck & Co As H | Use of sertindole for the preventive treatment of suicidal behaviour |
CN101362704B (zh) * | 2008-09-23 | 2012-04-18 | 上海医药工业研究院 | N-(4-氟苯基)-n-(2-羧基-4-氯苯基)甘氨酸的制备方法 |
CN101362748B (zh) * | 2008-09-23 | 2012-09-05 | 上海医药工业研究院 | 一种制备舍吲哚的方法 |
CN101591330B (zh) * | 2009-06-29 | 2013-03-06 | 上海医药工业研究院 | 舍吲哚晶型及其制备方法 |
CN101899036B (zh) * | 2010-07-22 | 2012-12-19 | 郑州大学 | 以烷基咪唑型离子液体为溶剂制备舍吲哚的方法 |
CN103214463A (zh) * | 2013-03-30 | 2013-07-24 | 北京德众万全药物技术开发有限公司 | 一种新的舍吲哚制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3131527A1 (de) * | 1981-08-08 | 1983-02-24 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 1-phenyl-2-aminocarbonylindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
IT1271352B (it) * | 1993-04-08 | 1997-05-27 | Boehringer Ingelheim Italia | Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale |
DE19532054A1 (de) * | 1995-08-31 | 1997-03-06 | Hoechst Ag | Verfahren zur Herstellung von N-Carboxymethylen-4-chlor-anthranilsäure, sowie deren Dialkylestern |
-
1998
- 1998-05-07 CN CNB988048353A patent/CN1243001C/zh not_active Expired - Fee Related
- 1998-05-07 ES ES98919090T patent/ES2213897T3/es not_active Expired - Lifetime
- 1998-05-07 EP EP02018748A patent/EP1260511B1/en not_active Expired - Lifetime
- 1998-05-07 NZ NZ500700A patent/NZ500700A/xx not_active IP Right Cessation
- 1998-05-07 ES ES02018748T patent/ES2234961T3/es not_active Expired - Lifetime
- 1998-05-07 WO PCT/DK1998/000183 patent/WO1998051685A1/en active IP Right Grant
- 1998-05-07 EP EP98919090A patent/EP0983264B1/en not_active Expired - Lifetime
- 1998-05-07 CA CA002288334A patent/CA2288334C/en not_active Expired - Fee Related
- 1998-05-07 PT PT02018748T patent/PT1260511E/pt unknown
- 1998-05-07 EA EA199901021A patent/EA003248B1/ru not_active IP Right Cessation
- 1998-05-07 SK SK54-2006A patent/SK285410B6/sk not_active IP Right Cessation
- 1998-05-07 US US09/423,096 patent/US6335463B1/en not_active Expired - Fee Related
- 1998-05-07 PL PL336578A patent/PL191174B1/pl not_active IP Right Cessation
- 1998-05-07 DE DE69821477T patent/DE69821477T2/de not_active Expired - Lifetime
- 1998-05-07 KR KR1019997010319A patent/KR100546477B1/ko not_active IP Right Cessation
- 1998-05-07 TR TR1999/02759T patent/TR199902759T2/xx unknown
- 1998-05-07 CZ CZ0396099A patent/CZ298509B6/cs not_active IP Right Cessation
- 1998-05-07 DE DE69828454T patent/DE69828454T2/de not_active Expired - Lifetime
- 1998-05-07 DK DK98919090T patent/DK0983264T3/da active
- 1998-05-07 CZ CZ20050518A patent/CZ299015B6/cs not_active IP Right Cessation
- 1998-05-07 AT AT02018748T patent/ATE286047T1/de active
- 1998-05-07 IL IL13246198A patent/IL132461A/xx not_active IP Right Cessation
- 1998-05-07 AU AU72062/98A patent/AU731835B2/en not_active Ceased
- 1998-05-07 PT PT98919090T patent/PT983264E/pt unknown
- 1998-05-07 DK DK02018748T patent/DK1260511T3/da active
- 1998-05-07 SI SI9830747T patent/SI1260511T1/xx unknown
- 1998-05-07 SI SI9830608T patent/SI0983264T1/xx unknown
- 1998-05-07 BR BR9808740-1A patent/BR9808740A/pt not_active Application Discontinuation
- 1998-05-07 SK SK1527-99A patent/SK285221B6/sk not_active IP Right Cessation
- 1998-05-07 TR TR2000/03421T patent/TR200003421T2/xx unknown
- 1998-05-07 CN CNB2003101046201A patent/CN1301963C/zh not_active Expired - Fee Related
- 1998-05-07 JP JP54871198A patent/JP2002515904A/ja not_active Ceased
- 1998-05-07 KR KR1020057015729A patent/KR100627616B1/ko not_active IP Right Cessation
- 1998-05-07 HU HU0003365A patent/HU226858B1/hu not_active IP Right Cessation
- 1998-05-07 AT AT98919090T patent/ATE258929T1/de active
- 1998-07-05 UA UA99116293A patent/UA61105C2/uk unknown
-
1999
- 1999-10-19 IS IS5222A patent/IS2158B/is unknown
- 1999-11-04 BG BG103857A patent/BG64007B1/bg unknown
- 1999-11-08 NO NO19995457A patent/NO325918B1/no not_active IP Right Cessation
-
2001
- 2001-01-05 HK HK01100142A patent/HK1029583A1/xx not_active IP Right Cessation
-
2006
- 2006-05-15 IS IS8468A patent/IS2324B/is unknown
-
2007
- 2007-12-03 NO NO20076208A patent/NO331924B1/no not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007522206A (ja) * | 2004-02-12 | 2007-08-09 | エスケー ケミカルズ カンパニー リミテッド | 置換ベンゾピラン化合物の製造方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002515904A (ja) | セルトインドールの製造方法 | |
JP4048119B2 (ja) | 2−(4−クロロベンゾイルアミノ)−3−[2(1h)−キノールリノン−4−イル]プロピオン酸の製造方法 | |
JP2005500322A (ja) | 3−フェニルイソセリンの製法 | |
JP4227671B2 (ja) | エプロサルタンの製造方法 | |
JP4433365B2 (ja) | 4−(2−メチル−1−イミダゾリル)−2,2−ジフェニルブタンアミドの製造方法 | |
US9290439B2 (en) | Process for preparing cinacalcet and pharmaceutically acceptable salts thereof | |
EP1535900B1 (en) | Process for the preparation of nateglinide, preferably in b-form | |
JP2587336B2 (ja) | 塩酸ベバントロールの製造方法 | |
CA2486883C (en) | Method of manufacturing sertindole | |
JP5087059B2 (ja) | 4−(2−メチル−1−イミダゾリル)−2,2−ジフェニルブタンアミドの製造方法 | |
HRP980395A2 (en) | Method of manufacturing sertindole | |
JP3831421B2 (ja) | アミノエチルグリシンを製造する方法 | |
JP3257779B2 (ja) | タートラニル酸類の製造法 | |
MXPA99010191A (en) | Method of manufacturing sertindole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050427 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090602 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090803 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090907 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20091221 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100126 |